Literature DB >> 19959209

Do galectins play a role in venous thrombosis? a review.

Jose A Diaz1, Eduardo Ramacciotti, Thomas W Wakefield.   

Abstract

Galectins are a family of carbohydrate-binding proteins that have a high affinity to galactosides on cell surfaces and extra cellular glycoproteins. They are involved in a variety of biological functions, including modulation of cell apoptosis, cell activation and inflammation. Our laboratory has recently identified galectin-3 binding protein (Gal-3BP) as being up-regulated in a microparticle proteomics analysis for deep venous thrombosis (DVT) patients compared to negative controls. P-selectin, another glycoprotein involved in thrombus propagation, has proven a promising target for DVT management and has been widely studied by our group. Galectins are involved in P-selectin expression and can potentially be implicated in the venous thrombogenesis process. The function of galectins, their role in inflammation and thrombosis as well as their potential implications as a new pharmacological target for DVT management are reviewed in this manuscript. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19959209      PMCID: PMC2860062          DOI: 10.1016/j.thromres.2009.11.011

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  49 in total

1.  Newer biomarkers in heart failure.

Authors:  Sachin Gupta; Mark H Drazner; James A de Lemos
Journal:  Heart Fail Clin       Date:  2009-10       Impact factor: 3.179

2.  Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulation.

Authors:  Daniel D Myers; Shirley K Wrobleski; Chris Longo; Patricia W Bedard; Neelu Kaila; George D Shaw; Frank J Londy; Suzan E Rohrer; Beverly A Fex; Paul J Zajkowski; Thomas R Meier; Angela E Hawley; Diana M Farris; Nicole E Ballard; Peter K Henke; Robert G Schaub; Thomas W Wakefield
Journal:  Thromb Haemost       Date:  2007-03       Impact factor: 5.249

3.  Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis.

Authors:  Neil C Henderson; Alison C Mackinnon; Sarah L Farnworth; Tiina Kipari; Christopher Haslett; John P Iredale; Fu-Tong Liu; Jeremy Hughes; Tariq Sethi
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

4.  Leukocyte- and platelet-derived microparticles correlate with thrombus weight and tissue factor activity in an experimental mouse model of venous thrombosis.

Authors:  Eduardo Ramacciotti; Angela E Hawley; Diana M Farris; Nicole E Ballard; Shirley K Wrobleski; Daniel D Myers; Peter K Henke; Thomas W Wakefield
Journal:  Thromb Haemost       Date:  2009-04       Impact factor: 5.249

5.  Prophylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulation.

Authors:  Thomas R Meier; Daniel D Myers; Shirley K Wrobleski; Paul J Zajkowski; Angela E Hawley; Patricia W Bedard; Nicole E Ballard; Frank J Londy; Neelu Kaila; George P Vlasuk; Robert G Schaub; Thomas W Wakefield
Journal:  Thromb Haemost       Date:  2008-02       Impact factor: 5.249

6.  On the trail of microparticles.

Authors:  Nigel Mackman
Journal:  Circ Res       Date:  2009-04-24       Impact factor: 17.367

7.  Silencing of galectin-3 changes the gene expression and augments the sensitivity of gastric cancer cells to chemotherapeutic agents.

Authors:  Teak-Chin Cheong; Ji-Young Shin; Kyung-Hee Chun
Journal:  Cancer Sci       Date:  2009-09-14       Impact factor: 6.716

Review 8.  Galectins in the tumor endothelium: opportunities for combined cancer therapy.

Authors:  Victor L J L Thijssen; Françoise Poirier; Linda G Baum; Arjan W Griffioen
Journal:  Blood       Date:  2007-06-25       Impact factor: 22.113

9.  Synthetic inhibitors of galectin-1 and -3 selectively modulate homotypic cell aggregation and tumor cell apoptosis.

Authors:  Ida Iurisci; Albana Cumashi; Andrei A Sherman; Yury E Tsvetkov; Nicola Tinari; Enza Piccolo; Maurizia D'Egidio; Vincenzo Adamo; Clara Natoli; Gabriel A Rabinovich; Stefano Iacobelli; Nikolay E Nifantiev
Journal:  Anticancer Res       Date:  2009-01       Impact factor: 2.480

10.  Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity.

Authors:  Shumei Song; Nachman Mazurek; Chunming Liu; Yunjie Sun; Qing Qing Ding; Kaifeng Liu; Mien-Chie Hung; Robert S Bresalier
Journal:  Cancer Res       Date:  2009-02-03       Impact factor: 12.701

View more
  13 in total

Review 1.  Platelets and galectins.

Authors:  Mirta Schattner
Journal:  Ann Transl Med       Date:  2014-09

2.  Galectin-3 expression in response to LPS, immunomodulatory drugs and exogenously added galectin-3 in monocyte-like THP-1 cells.

Authors:  Sanja Dabelic; Ruder Novak; Sandra Supraha Goreta; Jerka Dumic
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-08-15       Impact factor: 2.416

3.  The role of galectin-3 and galectin-3-binding protein in venous thrombosis.

Authors:  Elise P DeRoo; Shirley K Wrobleski; Evelyn M Shea; Ramsey K Al-Khalil; Angela E Hawley; Peter K Henke; Daniel D Myers; Thomas W Wakefield; Jose A Diaz
Journal:  Blood       Date:  2014-11-26       Impact factor: 22.113

4.  Comparison among plasma-derived clotting factor VIII by using monodimensional gel electrophoresis and mass spectrometry.

Authors:  Anna Maria Timperio; Federica Gevi; Giuliano Grazzini; Stefania Vaglio; Lello Zolla
Journal:  Blood Transfus       Date:  2010-06       Impact factor: 3.443

5.  Pre-feeding of a glycolipid binding protein LEC-8 from Caenorhabditis elegans revealed enhanced tolerance to Cry1Ac toxin in Helicoverpa armigera.

Authors:  Gang Ma; Otto Schmidt; Mike Keller
Journal:  Results Immunol       Date:  2012-05-14

6.  Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation.

Authors:  Isabel Fort-Gallifa; Anna Hernández-Aguilera; Anabel García-Heredia; Noemí Cabré; Fedra Luciano-Mateo; Josep M Simó; Vicente Martín-Paredero; Jordi Camps; Jorge Joven
Journal:  Int J Mol Sci       Date:  2017-05-04       Impact factor: 5.923

Review 7.  A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus.

Authors:  Christoffer T Nielsen; Ole Østergaard; Niclas S Rasmussen; Søren Jacobsen; Niels H H Heegaard
Journal:  Clin Proteomics       Date:  2017-04-08       Impact factor: 3.988

8.  Is Swine-origin Influenza a Predisposing Factor for Deep Vein Thrombosis?

Authors:  Müge Gökçe; Sule Unal; Selin Aytaç; Ateş Kara; Mehmet Ceyhan; Murat Tuncer; Fatma Gümrük
Journal:  Turk J Haematol       Date:  2012-06-15       Impact factor: 1.831

9.  Timing of Endovascular Interventions for Iliac Vein Compression Syndrome With Thrombus.

Authors:  Wenxu Jin; Guanfeng Yu; Jingyong Huang; Kangkang Lu; Chongqing Huang
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

10.  Galectin-3 and Venous Thromboembolism Incidence: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Oluwaseun E Fashanu; Susan R Heckbert; David Aguilar; Paul N Jensen; Christie M Ballantyne; Saonli Basu; Ron C Hoogeveen; Christopher deFilippi; Mary Cushman; Aaron R Folsom
Journal:  Res Pract Thromb Haemost       Date:  2017-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.